Skip to content

Pharmaceutical Consultation and Exchange Between the Pharmacy and the Hospital

Pharmaceutical Consultation and Exchange Between the Pharmacy and the Hospital

Status
Withdrawn
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04811183
Acronym
EPHET
Enrollment
0
Registered
2021-03-23
Start date
2023-06-23
Completion date
2023-06-23
Last updated
2025-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Keywords

pharmaceutical consultations, adherence

Brief summary

Investigators hypothesize that the implementation of a hospital pharmacy consultation and the transmission of its report to pharmacies may improve knowledge, adherence and encourage the development of pharmacist medication reviews. A before-and-after study of the implementation of pharmaceutical consultations will allow the investigators to evaluate the validity of the hypothesis.

Interventions

Selection of patients for a pharmaceutical consultation with collection of non-opposition and scheduling of telephone interviews or by teleconsultations at one week after hospitalization. Data collection through interviews using a telephone questionnaire (or by teleconsultation) one week after consultation. Elements on knowledge and adherence of treatment will be collected.

Sponsors

Hospices Civils de Lyon
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult patient admitted in the endocrinology service for a type 2 Diabetes who has more than 5 concomitant treatments * Adult patient that is being discharged for a return home * Good comprehension of French

Exclusion criteria

* Bad comprehension of French

Design outcomes

Primary

MeasureTime frameDescription
Evolution in the knowledge about the patient's conditionOne weekTreatment knowledge, knowledge about the pathology and knowledge of hygienic and dietary measures will be assessed with a questionnaire giving a score from 0 to 2 -the higher the score, the better the outcome-. Comparison of the knowledge of the treatment between the first questionnaire conducted during the pharmaceutical consultation and the second questionnaire one week after the consultation. Statistical evaluation by comparative tests between the two questionnaires.
Evolution in the adherenceOne weekEvaluation of the patient's adherence to his treatment through a questionnaire giving a score between 0 to 6 -the higher the score, the better the outcome-. Comparison of the scores between the first questionnaire conducted during the pharmaceutical consultation and the second questionnaire one week after the consultation. Statistical evaluation by comparative tests between the two questionnaires.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026